Diagnostic accuracy of cerebrospinal fluid pleocytosis in suspected meningoencephalomyelitis of unknown origin in canines

PICO question: In canines with suspected meningoencephalomyelitis of unknown origin (MUO) [population], does cerebrospinal fluid analysis for pleocytosis [intervention], compared with histopathology [comparison], accurately identify underlying noninfectious inflammatory central nervous system (CNS) disease [outcome]? Category of research: Diagnosis. Number and type of study designs reviewed: Three retrospective case series and one systematic review. Strength of evidence: Moderate. Outcomes reported: The four studies included collectively reported the presence or absence of cerebrospinal fluid (CSF) pleocytosis in dogs with histopathologically confirmed noninfectious inflammatory CNS disease or clinically diagnosed MUO where applicable. Pleocytosis is defined as a total nucleated cell count (TNCC) above the laboratory reference interval. The first study reported pleocytosis in all 22 dogs evaluated with granulomatous meningoencephalomyelitis (GME). In contrast, the second paper identified normal TNCC in a substantial proportion of GME cases, a finding mirrored by the third study across a significant number of GME, necrotising meningoencephalitis (NME), and clinically diagnosed MUO patients. Finally, the fourth study documented normal repeat CSF TNCC levels in a single dog with progressive NME within a small sample size. Conclusion: Cerebrospinal fluid pleocytosis supports a diagnosis of noninfectious inflammatory CNS disease in dogs with suspected MUO but does not exclude disease when absent. Furthermore, CSF findings cannot reliably distinguish between inflammatory disease subtypes. Therefore, CSF analysis should be interpreted alongside neurological examination, magnetic resonance imaging (MRI) findings, and exclusion of infectious diseases rather than used as a standalone diagnostic test. How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient's circumstances and owners' values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

Authors

Institutions

Publication Details

Journal
Veterinary Evidence
Published
2026-11-16
DOI
https://doi.org/10.18849/ve.v11i4.759
Primary Topic
Veterinary Orthopedics and Neurology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic accuracy of cerebrospinal fluid pleocytosis in suspected meningoencephalomyelitis of unknown origin in canines

Zachary Horowitz
1 links
Veterinary Evidence
Veterinary Orthopedics and Neurology
article

Diagnostic accuracy of cerebrospinal fluid pleocytosis in suspected meningoencephalomyelitis of unknown origin in canines

Zachary Horowitz
article en

Abstract

PICO question: In canines with suspected meningoencephalomyelitis of unknown origin (MUO) [population], does cerebrospinal fluid analysis for pleocytosis [intervention], compared with histopathology [comparison], accurately identify underlying noninfectious inflammatory central nervous system (CNS) disease [outcome]? Category of research: Diagnosis. Number and type of study designs reviewed: Three retrospective case series and one systematic review. Strength of evidence: Moderate. Outcomes reported: The four studies included collectively reported the presence or absence of cerebrospinal fluid (CSF) pleocytosis in dogs with histopathologically confirmed noninfectious inflammatory CNS disease or clinically diagnosed MUO where applicable. Pleocytosis is defined as a total nucleated cell count (TNCC) above the laboratory reference interval. The first study reported pleocytosis in all 22 dogs evaluated with granulomatous meningoencephalomyelitis (GME). In contrast, the second paper identified normal TNCC in a substantial proportion of GME cases, a finding mirrored by the third study across a significant number of GME, necrotising meningoencephalitis (NME), and clinically diagnosed MUO patients. Finally, the fourth study documented normal repeat CSF TNCC levels in a single dog with progressive NME within a small sample size. Conclusion: Cerebrospinal fluid pleocytosis supports a diagnosis of noninfectious inflammatory CNS disease in dogs with suspected MUO but does not exclude disease when absent. Furthermore, CSF findings cannot reliably distinguish between inflammatory disease subtypes. Therefore, CSF analysis should be interpreted alongside neurological examination, magnetic resonance imaging (MRI) findings, and exclusion of infectious diseases rather than used as a standalone diagnostic test. How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient's circumstances and owners' values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

Veterinary EvidenceVol. 11(4)
Royal Veterinary College (GB)
Royal Veterinary College
Good health and well-being
Veterinary Orthopedics and Neurology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon